Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers [Retraction]

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers [Retraction]

Yu G, Ali Z, Sajjad Khan A, et al. Int J Nanomedicine. 2021;16:3255-3273. At the authors request, the Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figures 9A, 9B and 9C with th...

Full description

Bibliographic Details
Main Authors:	Yu G, Ali Z, Sajjad Khan A, Ullah K, Jamshaid H, Zeb A, Imran M, Sarwar S, Choi HG, Din F
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-03-01
Series:	International Journal of Nanomedicine
Subjects:	breast cancer miltefosine nano lipid carriers bioavailability pharmacokinetics antitumor efficacy
Online Access:	https://www.dovepress.com/retraction-preparation-pharmacokinetics-and-antitumor-potential-of-mil-peer-reviewed-fulltext-article-IJN

Similar Items

Positive kidney profile of dogs with Leishmania sp. and treated with miltefosine
by: Danillo Brenno de Assis Torres, et al.
Published: (2024-03-01)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
by: Isabel M. Vincent, et al.
Published: (2015-10-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis
by: Nadav Astman, et al.
Published: (2024-09-01)

Development and evaluation of miltefosine-loaded nanoemulsions on in vitro culture of Toxoplasma gondii
by: Gholam Valizadeh, et al.
Published: (2024-04-01)

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
by: Manuela Gizzarelli, et al.
Published: (2023-06-01)

Investigation of in vitro Efficacy of Miltefosine on Chronic Cutaneous Leishmaniasis
by: Varol Tunalı, et al.
Published: (2022-06-01)

Effectiveness of Miltefosine Nanoemulsion Concerning the Treatment of Acute and Chronic Toxoplasmosis: In Vivo Study
by: Gholam Reza Valizadeh, et al.
Published: (2024-08-01)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
by: Lu Lu, et al.
Published: (2020-12-01)

Adamantylidene-substituted alkylphosphocholine TCAN26 is more active against Sporothrix schenckii than miltefosine
by: Luana Pereira Borba-Santos, et al.
Published: (2016-01-01)

The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil
by: Eliane de Morais-Teixeira, et al.
Published: (2011-06-01)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
by: Rachel L. Sadowsky, BA, et al.
Published: (2022-11-01)

Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana
by: Charlene Oliveira, et al.
Published: (2024-07-01)

Comparison of Pharmacokinetic Characteristics of Bilosomal Dispersion Versus Pure Solution of Oral Ropinirole Hydrochloride in Rats
by: Samer K. Ali, et al.
Published: (2024-07-01)

Thermoterapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia
by: Liliana López, et al.
Published: (2013-06-01)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
by: Sandrine Cojean, et al.
Published: (2012-04-01)

Antiparasitic properties of miltefosine-based nanoformulations against protozoan pathogen, Acanthamoeba castellanii
by: Noor Akbar, et al.
Published: (2022-01-01)

Evaluation of In Vitro Cytotoxic and Apoptotic Effects of Miltefosine on the Toxoplasma gondii RH Strain
by: Shahram Khademvatan, et al.
Published: (2024-02-01)

Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers
by: Wang Fengling, et al.
Published: (2017-09-01)

Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
by: Laura Fernanda Neira, et al.
Published: (2023-11-01)

Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers
by: Kazuaki Taguchi, et al.
Published: (2017-03-01)

Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol
by: Laura Manna, et al.
Published: (2015-05-01)

In Vitro Susceptibility to Miltefosine of <i>Leishmania infantum</i> (syn. <i>L.</i> <i>chagasi</i>) Isolates from Different Geographical Areas in Brazil
by: Caroline Ricce Espada, et al.
Published: (2021-06-01)

Critically Appraised Topic on Canine Leishmaniosis: Does Treatment with Antimonials and Allopurinol Have the Same Clinical and Clinicopathological Efficacy as Treatment with Miltefosine and Allopurinol, after One Month of Treatment?
by: Marina García, et al.
Published: (2024-05-01)

Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis
by: Lin Chen, et al.
Published: (2022-12-01)

Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study
by: Shunsuke Kondo, et al.
Published: (2024-01-01)

In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant <i>Fusarium</i> Strains
by: Mohsen Nosratabadi, et al.
Published: (2022-07-01)

Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
by: Krishna Pandey, et al.
Published: (2020-12-01)

Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine
by: Alexander C. Aichelburg, et al.
Published: (2008-11-01)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
by: Julián Ernesto Nicolás Gulin, et al.
Published: (2022-07-01)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with <i>Leishmania infantum</i>
by: Ana Isabel Olías-Molero, et al.
Published: (2023-02-01)

Pharmacokinetics of florfenicol following intravenous and intramuscular administration in dogs
by: Y.O. Birdane, et al.
Published: (2015-06-01)

Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant <i>Trichophyton indotineae</i>
by: Iman Haghani, et al.
Published: (2023-04-01)

Clinical Improvement of Disseminated Acanthamoeba Infection in a Patient with Advanced HIV Using a Non-Miltefosine-Based Treatment Regimen in a Low-Resource Setting
by: Denasha L. Reddy, et al.
Published: (2022-02-01)

The zinc cluster transcription factor Znc1 regulates Rta3-dependent miltefosine resistance in Candida albicans
by: Bernardo Ramírez-Zavala, et al.
Published: (2024-07-01)

Efficacy of Miltefosine and Artemether on infected Biomphalaria alexandrina snails with Schistosoma mansoni: immunological and histological studies
by: Abdel-Azeem H. H., et al.
Published: (2020-11-01)

Thermoterapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia Termoterapia efectiva y más segura que la miltefosina en el tratamiento de la leishmaniasis cutánea en Colombia
by: Liliana López, et al.
Published: (2013-06-01)

Preliminary Study on Pharmacokinetics and Antitumor Pharmacodynamics of Folic Acid Modified Crebanine Polyethyleneglycol-Polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles
by: Cheng X, et al.
Published: (2024-10-01)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2019-03-01)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
by: Lieselotte Van Bockstal, et al.
Published: (2020-08-01)